|
Body Mass and Mortality Relationships
|
Research Initiative
|
CDC
|
NCI
|
This collaboration between CDC and NIH is a study of the relationships between categories of body mass and mortality in the U.S. population.
|
|
Botulism Guidelines Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC
|
The NIH Clinical Center is participating in a working group with CDC to develop clinical guidelines for treatment of botulism and use of botulism antitoxin.
|
|
Brain Attack Coalition
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NINDS
|
The Brain Attack Coalition (BAC) is a group of public and private entities representing medical, scientific, advocacy, and government professionals from across the stroke continuum. The BAC is dedicated to setting direction, advancing knowledge, and communicating best practices to improve our ability to prevent and combat stroke.
|
|
Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG) Special Interest Group
|
Other
|
FDA, OSG
|
NICHD, NCI, NIDDK, OD/DPCPSI/ORWH
|
In August 2012, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) formed a trans-U.S. Department of Health and Human Services (HHS) scientific interest group, Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG), to provide an intellectual platform for the scientists from HHS agencies interested in breastfeeding and human lactation research activities.
|
|
Bridging Knowledge Gaps to Understand How Zika virus (ZIKV) Exposure and Infection Affect Child Development Workshop
|
Meeting/ Workshop
|
CDC, FDA, HRSA, OS
|
NICHD, FIC, NCI, NHGRI, NIAAA, NIAID, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR
|
ZIKV is a growing, global epidemic. ZIKV has been associated with numerous birth and developmental defects, such as microcephaly, and other pregnancy and birth-related problems, including miscarriages, stillbirths, and other in utero complications. Because of these health issues, it is imperative that the scientific community understand the effects of ZIKV on pregnancy and pregnancy outcomes. The purpose of this workshop is to identify optimal approaches for treating and caring for the generation of children exposed to ZIKV in the womb.
|
|
Burkholderia Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIAID
|
This interagency working group coordinates activities related to the Burkholderia research portfolios of NIAID, Biomedical Advanced Research and development Authority (BARDA), and Defense Threat Reduction Agency, and shares data related to the regulatory pathway of existing and novel medical countermeasures against melioidosis and glanders.
|
|
Cancer and Women''s Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
This formal agreement establishes the framework and procedures to enhance collaborations and exchange of information between the FDA’s Office of Women’s Health (OWH) and the NCI’s Center to Reduce Cancer Health Disparities (CRCHD). Working together, FDA and NCI seek to increase scientific knowledge and understanding of cancer in women through targeted basic, clinical, bio-behavioral, translational, and community-based participatory research approaches/efforts. FDA and NCI both recognize the need for a unified approach to advancing scientific knowledge related to cancer and women’s health. This harmonized approach will aid in advancing the public health of all women through innovation in cancer research and medical therapies.
|
|
Cancer Control Plan, Link, Act, Network with Evidence-Based Tools (P.L.A.N.E.T)
|
Resource Development
|
AHRQ, CDC, SAMHSA
|
NCI
|
Cancer control planners, program staff, and researchers have the same goals: to reduce cancer risk, the number of new cancer cases, and the number of deaths from cancer, as well as enhance the quality of life for cancer survivors. While many share the same goals, all do not have easy access to resources that can facilitate the transfer of evidence-based research findings into practice. This Cancer Control P.L.A.N.E.T. (Plan, Link, Act, Network with Evidence-based Tools) portal provides access to data and resources that can help planners, program staff, and researchers to design, implement and evaluate evidence-based cancer control programs.
|
|
Cancer Moonshot Blue Ribbon Panel
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/OSP, NCI
|
The Cancer Moonshot Blue Ribbon Panel led the efforts of seven working groups that developed recommendations to accelerate the pace of cancer research, so as to achieve a decade''s worth of progress in just five years. The panel and the working groups consisted of scientific experts from various fields that span academia, industry, government, and advocacy organizations.
|
|
CDC and HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OAR
|
The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, and HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis.
|